BIOMAT Database Logo BIOMAT Database Logo

In response to "In utero exposure to methotrexate and risk of congenital malformations". 2015

April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000013 Congenital Abnormalities Malformations of organs or body parts during development in utero. Birth Defects,Congenital Defects,Deformities,Fetal Anomalies,Fetal Malformations,Abnormalities, Congenital,Defects, Congenital,Abnormality, Congenital,Anomaly, Fetal,Birth Defect,Congenital Abnormality,Congenital Defect,Defect, Birth,Defect, Congenital,Deformity,Fetal Anomaly,Fetal Malformation,Malformation, Fetal
D018811 Maternal Exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure. Exposure, Maternal,Exposures, Maternal,Maternal Exposures

Related Publications

April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
In utero exposure to methotrexate and risk of congenital malformations.
October 2015, American journal of medical genetics. Part A,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
In utero exposure to antibiotics and risk of congenital malformations: a population-based study.
December 2019, American journal of obstetrics and gynecology,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines.
October 2021, Alimentary pharmacology & therapeutics,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero.
January 2013, Epilepsia,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
Editorial: the risk of chronic diseases and congenital malformations during childhood and adolescence after in utero drug exposure to thiopurines.
October 2021, Alimentary pharmacology & therapeutics,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US.
February 2023, JAMA psychiatry,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
In utero first trimester exposure to low-dose methotrexate with increased fetal nuchal translucency and associated malformations.
June 2002, Prenatal diagnosis,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
Methotrexate-induced congenital malformations.
November 1971, The Medical journal of Australia,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
Methotrexate-induced congenital malformations.
June 1968, The Journal of pediatrics,
April L Dawson, and Tiffany Riehle-Colarusso, and Jennita Reefhuis, and J Fernando Arena, and
In utero exposure to systemic antibiotics vs reference penicillins was not linked to congenital malformations.
May 2020, Annals of internal medicine,
Copied contents to your clipboard!